$GANX
Gain Therapeutics, Inc.

2023 Q1 Form 10-K Financial Statement

#000155837023004460 Filed on March 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $55.18K $0.00 $140.1K
YoY Change 22.61% -100.0% -15.08%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.494M $2.287M $9.540M
YoY Change 40.33% 28.54% 39.74%
% of Gross Profit
Research & Development $2.791M $2.274M $8.377M
YoY Change 79.33% 54.42% 16.93%
% of Gross Profit
Depreciation & Amortization $19.24K $18.11K $64.17K
YoY Change 134.4% 213.32% 314.41%
% of Gross Profit
Operating Expenses $5.285M $4.561M $17.92M
YoY Change 58.54% 40.26% 28.06%
Operating Profit -$5.230M -$17.78M
YoY Change 59.03% 28.58%
Interest Expense $109.2K -$35.16K $279.3K
YoY Change 523.64% 81.14% -562.25%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.121M -$4.596M -$17.50M
YoY Change 56.55% 42.38% 26.0%
Income Tax $16.73K $78.11K $92.98K
% Of Pretax Income
Net Earnings -$5.137M -$4.674M -$17.59M
YoY Change 56.98% 45.17% 26.64%
Net Earnings / Revenue -9310.11% -12555.13%
Basic Earnings Per Share -$0.43 -$1.48
Diluted Earnings Per Share -$0.43 -$0.39 -$1.48
COMMON SHARES
Basic Shares Outstanding 11.88M 11.88M 11.88M
Diluted Shares Outstanding 11.94M 11.88M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.82M $20.14M $20.14M
YoY Change -48.12% -45.4% -45.4%
Cash & Equivalents $5.988M $7.312M $4.401M
Short-Term Investments $14.90M $17.23M $17.23M
Other Short-Term Assets $1.336M $761.4K $761.4K
YoY Change -27.31% 17.88% 17.88%
Inventory
Prepaid Expenses
Receivables
Other Receivables $33.26K $87.43K
Total Short-Term Assets $19.32M $21.09M $21.09M
YoY Change -46.91% -44.09% -44.09%
LONG-TERM ASSETS
Property, Plant & Equipment $144.6K $144.4K $1.018M
YoY Change 35.52% 36.22% -15.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $988.4K $1.941M $1.941M
YoY Change
Other Assets $48.78K $48.32K $48.32K
YoY Change 1.48% -9.5% -9.5%
Total Long-Term Assets $2.001M $3.008M $3.008M
YoY Change 65.81% 138.17% 138.16%
TOTAL ASSETS
Total Short-Term Assets $19.32M $21.09M $21.09M
Total Long-Term Assets $2.001M $3.008M $3.008M
Total Assets $21.32M $24.10M $24.10M
YoY Change -43.29% -38.18% -38.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $1.626M $1.626M
YoY Change 3.85% 190.13% 190.13%
Accrued Expenses $1.263M $1.082M $1.972M
YoY Change 92.42% 58.72% 44.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $109.2K $108.1K $108.1K
YoY Change 26.06% 4.15% 4.15%
Total Short-Term Liabilities $5.155M $4.125M $4.125M
YoY Change 22.24% 61.61% 61.61%
LONG-TERM LIABILITIES
Long-Term Debt $478.3K $495.3K $495.3K
YoY Change -14.73% -16.12% -16.12%
Other Long-Term Liabilities $550.5K $599.4K $599.4K
YoY Change -44.56% -41.5% -41.5%
Total Long-Term Liabilities $1.029M $1.095M $1.095M
YoY Change -33.79% -32.22% -32.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.155M $4.125M $4.125M
Total Long-Term Liabilities $1.029M $1.095M $1.095M
Total Liabilities $6.184M $5.220M $5.220M
YoY Change 7.16% 25.25% 25.25%
SHAREHOLDERS EQUITY
Retained Earnings -$38.52M -$20.93M
YoY Change 84.06% 197.45%
Common Stock $1.209K $1.189K
YoY Change 1.68% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.14M $18.88M $18.88M
YoY Change
Total Liabilities & Shareholders Equity $21.32M $24.10M $24.10M
YoY Change -43.29% -38.18% -38.18%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.137M -$4.674M -$17.59M
YoY Change 56.98% 45.17% 26.64%
Depreciation, Depletion And Amortization $19.24K $18.11K $64.17K
YoY Change 134.4% 213.32% 314.41%
Cash From Operating Activities -$4.217M -$3.905M -$14.69M
YoY Change 72.32% -5.83% 18.81%
INVESTING ACTIVITIES
Capital Expenditures $11.05K $9.390K $119.0K
YoY Change 41.21% -184.59% 26.26%
Acquisitions
YoY Change
Other Investing Activities $2.118M $143.2K -$14.66M
YoY Change
Cash From Investing Activities $2.107M $133.8K -$14.77M
YoY Change -27026.26% -1305.68% 15582.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 748.9K -21.58K -78.77K
YoY Change -2072.16% 121.79% -100.19%
NET CHANGE
Cash From Operating Activities -4.217M -3.905M -14.69M
Cash From Investing Activities 2.107M 133.8K -14.77M
Cash From Financing Activities 748.9K -21.58K -78.77K
Net Change In Cash -1.323M -3.792M -29.57M
YoY Change -47.96% -8.99% -200.55%
FREE CASH FLOW
Cash From Operating Activities -$4.217M -$3.905M -$14.69M
Capital Expenditures $11.05K $9.390K $119.0K
Free Cash Flow -$4.228M -$3.914M -$14.81M
YoY Change 72.22% -5.35% 18.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M26D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M28D
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11883368
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001819411
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.1353521
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11883368
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11883368
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11883368
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11883368
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40237
CY2022 dei Entity Registrant Name
EntityRegistrantName
GAIN THERAPEUTICS, INC
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1726310
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
4800 Montgomery Lane
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 220
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
CY2022 dei City Area Code
CityAreaCode
301
CY2022 dei Local Phone Number
LocalPhoneNumber
500-1556
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
GANX
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
38800000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11883368
CY2022 dei Auditor Firm
AuditorFirmId
1460
CY2022 dei Auditor Name
AuditorName
Ernst & Young AG
CY2022 dei Auditor Location
AuditorLocation
Lugano, Switzerland
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7311611
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36880673
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
12826954
CY2022Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
103877
CY2021Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
113586
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
848854
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
727785
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21091296
CY2021Q4 us-gaap Assets Current
AssetsCurrent
37722044
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1941488
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
144379
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105986
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
213967
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
202609
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
659933
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
901042
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
30818
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
31279
CY2022Q4 ganx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
17506
CY2021Q4 ganx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
22111
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3008091
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1263027
CY2022Q4 us-gaap Assets
Assets
24099387
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133928
CY2022 us-gaap Sublease Income
SubleaseIncome
7468
CY2021 us-gaap Sublease Income
SubleaseIncome
31066
CY2022 us-gaap Revenues
Revenues
140108
CY2021Q4 us-gaap Assets
Assets
38985071
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1626100
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
560479
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229080
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
219137
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2106756
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1402600
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
55180
CY2021Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
266504
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
108135
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
103826
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4125251
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2552546
CY2022Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
157580
CY2021Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
329458
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
441784
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
695053
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
495258
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
590468
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1094622
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1614979
CY2022Q4 us-gaap Liabilities
Liabilities
5219873
CY2021Q4 us-gaap Liabilities
Liabilities
4167525
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11883368
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1189
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1189
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57358895
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
55832461
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
35627
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-90645
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20925459
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7034853
CY2022Q4 ganx Income Loss For Period
IncomeLossForPeriod
-17590738
CY2021Q4 ganx Income Loss For Period
IncomeLossForPeriod
-13890606
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18879514
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
34817546
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24099387
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38985071
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132640
CY2021 us-gaap Revenues
Revenues
164994
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8377290
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7164229
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9539863
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6826938
CY2022 us-gaap Operating Expenses
OperatingExpenses
17917153
CY2021 us-gaap Operating Expenses
OperatingExpenses
13991167
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-17777045
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-13826173
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
375357
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12495
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-96074
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-72920
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17497762
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13886598
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
92976
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4008
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17590738
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13890606
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11883368
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11883368
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10165404
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10165404
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17590738
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13890606
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-94279
CY2022 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-227131
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
101780
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6580
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
163833
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
126272
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
62053
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17464466
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13828553
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
34817546
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1526434
CY2022 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-227131
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6580
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-94279
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17590738
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18879514
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6201989
CY2021 ganx Issuance Of Common Stock In Ipo Net Of Issuance Costs
IssuanceOfCommonStockInIpoNetOfIssuanceCosts
40558522
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12217
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
839371
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1034000
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
101780
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
163833
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13890606
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
34817546
CY2022 us-gaap Profit Loss
ProfitLoss
-17590738
CY2021 us-gaap Profit Loss
ProfitLoss
-13890606
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64168
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15484
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1526434
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
839371
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
206861
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1034000
CY2021 ganx Adjustments For Capitalization Of Internal Use Software Classified As Operating Activities
AdjustmentsForCapitalizationOfInternalUseSoftwareClassifiedAsOperatingActivities
34135
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8264
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
114005
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
534502
CY2022 ganx Increase Decrease In Value Added Tax Credits
IncreaseDecreaseInValueAddedTaxCredits
-3631
CY2021 ganx Increase Decrease In Value Added Tax Credits
IncreaseDecreaseInValueAddedTaxCredits
71618
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2901
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-33979
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1066707
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-521394
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
711073
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
665460
CY2022 ganx Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset
NonCashIncreaseDecreaseInDefinedBenefitPensionPlanObligationAsset
58696
CY2021 ganx Non Cash Increase Decrease In Defined Benefit Pension Plan Obligation Asset
NonCashIncreaseDecreaseInDefinedBenefitPensionPlanObligationAsset
55326
CY2022 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-208343
CY2021 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
34701
CY2022 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-1514858
CY2021 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
329784
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14692139
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12365670
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
118953
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
94212
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
17735355
CY2022 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3079495
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14774813
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-94212
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
42629998
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
853488
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
78774
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
21951
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12216
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-78774
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41766775
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-23797
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100778
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29569523
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29407671
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36911952
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7504281
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7342429
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36911952
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2740
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4469
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
10
CY2021Q1 ganx Preferred Stock To Common Stock Conversion Ratio
PreferredStockToCommonStockConversionRatio
1
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
158576
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
165156
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of our consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates judgments and, assumptions including those related to recognition of accrued expenses, defined benefit pension liability, share-based compensation, and recognition of research grants. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. Changes in estimates are recorded in the period in which they become known. To the extent that material differences arise between the estimates and actual results, the Company’s future results of operations will be affected. </p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Concentrations of credit risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has no significant off-balance sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that may expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents which are deposited in accredited financial institutions in excess of federally insured limits. The Company deposits its cash and cash equivalents in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p>
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
213967
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
202609
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
46382
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7311611
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36880673
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
30818
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
31279
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
14862721
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
94279
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
14768442
CY2022Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
103877
CY2021Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
113586
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
552882
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
498252
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
87430
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
81862
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
208542
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
147671
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
848854
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
727785
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
197708
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
134375
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
53329
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28389
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
144379
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105986
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2022 us-gaap Depreciation
Depreciation
26632
CY2021 us-gaap Depreciation
Depreciation
15484
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
659933
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
901042
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229080
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
219137
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
441784
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
695053
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0153
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0186
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
228739
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
191329
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
242837
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
224325
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
164775
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
54251
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
686188
CY2022Q4 ganx Adjustment To Reconcile Operating Lease Liabilities Amounts Representing Interest Or Imputed Interest
AdjustmentToReconcileOperatingLeaseLiabilitiesAmountsRepresentingInterestOrImputedInterest
15324
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
670864
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1626100
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
560479
CY2022Q4 ganx Payable For Social Securities Current
PayableForSocialSecuritiesCurrent
256798
CY2021Q4 ganx Payable For Social Securities Current
PayableForSocialSecuritiesCurrent
255068
CY2022Q4 ganx Accrued Payroll Current
AccruedPayrollCurrent
660556
CY2021Q4 ganx Accrued Payroll Current
AccruedPayrollCurrent
465382
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1082091
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
681770
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
107311
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
380
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2106756
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1402600
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
55180
CY2021Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
266504
CY2022Q4 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
2161936
CY2021Q4 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
1669104
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
15875
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
3243
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
603393
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
108135
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
86508
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
86508
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
86508
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
86508
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
149226
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11883368
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11883368
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
960216
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.46
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.13
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M23D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
163237
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1005800
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.49
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.80
CY2022 ganx Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y25D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
86354
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
3.66
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.12
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1879662
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.94
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.42
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.49
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.27
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0339
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0098
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.49
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.27
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1526434
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
839371
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3503000
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-17341701
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7601640
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-156061
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-6284958
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17497762
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13886598
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
92976
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4008
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
92976
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4008
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
92976
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4008
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
34289160
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
18239792
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2140174
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2243668
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
6283703
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1677610
CY2022Q4 ganx Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Foreign
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostForeign
41093
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
399538
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
253439
CY2022Q4 ganx Deferred Tax Assets Fmw Warrant
DeferredTaxAssetsFmwWarrant
278198
CY2021Q4 ganx Deferred Tax Assets Fmw Warrant
DeferredTaxAssetsFmwWarrant
284531
CY2022Q4 ganx Deferred Tax Assets Patent Expenses
DeferredTaxAssetsPatentExpenses
202149
CY2021Q4 ganx Deferred Tax Assets Patent Expenses
DeferredTaxAssetsPatentExpenses
106936
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
117371
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
82927
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9462226
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4649111
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
20011
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
16118
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
20011
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
16118
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9442215
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4632993
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0622
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0652
CY2022 ganx Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0017
CY2021 ganx Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0010
CY2022 ganx Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
-0.0013
CY2021 ganx Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
0.0013
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0012
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0003
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2733
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2752
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0053
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 ganx Expense For Interest And Penalties Related To Uncertain Tax Position Recognized In Statement Of Operations
ExpenseForInterestAndPenaltiesRelatedToUncertainTaxPositionRecognizedInStatementOfOperations
0
CY2022 ganx Expense For Interest And Penalties Related To Uncertain Tax Position Recognized In Statement Of Operations
ExpenseForInterestAndPenaltiesRelatedToUncertainTaxPositionRecognizedInStatementOfOperations
0

Files In Submission

Name View Source Status
0001558370-23-004460-index-headers.html Edgar Link pending
0001558370-23-004460-index.html Edgar Link pending
0001558370-23-004460.txt Edgar Link pending
0001558370-23-004460-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ganx-20221231.xsd Edgar Link pending
ganx-20221231x10k.htm Edgar Link pending
ganx-20221231x10k001.jpg Edgar Link pending
ganx-20221231x10k002.jpg Edgar Link pending
ganx-20221231x10k003.jpg Edgar Link pending
ganx-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ganx-20221231x10k004.jpg Edgar Link pending
ganx-20221231x10k005.jpg Edgar Link pending
ganx-20221231x10k006.jpg Edgar Link pending
ganx-20221231x10k007.jpg Edgar Link pending
ganx-20221231x10k008.jpg Edgar Link pending
ganx-20221231x10k009.jpg Edgar Link pending
ganx-20221231x10k010.jpg Edgar Link pending
ganx-20221231x10k011.jpg Edgar Link pending
ganx-20221231x10k012.jpg Edgar Link pending
ganx-20221231x10k013.jpg Edgar Link pending
ganx-20221231x10k014.jpg Edgar Link pending
ganx-20221231x10k015.jpg Edgar Link pending
ganx-20221231xex23d1.htm Edgar Link pending
ganx-20221231xex31d1.htm Edgar Link pending
ganx-20221231xex31d2.htm Edgar Link pending
ganx-20221231xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
ganx-20221231_def.xml Edgar Link unprocessable
ganx-20221231_lab.xml Edgar Link unprocessable
ganx-20221231_pre.xml Edgar Link unprocessable
ganx-20221231x10k_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending